Stephen T. Isaacs has served as our Chairman, President and Chief Executive Officer since 2008. Prior to Aduro, in 1991, Mr. Isaacs founded Cerus Corporation, a biomedical products company that commercialized the Intercept Blood Systems. He served as President and Chief Executive Officer of Cerus from 1991 to 2004. Prior to Cerus, Mr. Isaacs founded and served as Chief Executive Officer and President of HRI Associates and HRI Research, both biotechnology companies focused on research and development. He held a non-teaching faculty position in the Department of Chemistry at the University of California, Berkeley, from 1978 to 1986. Mr. Isaacs has published over 20 peer-reviewed scientific articles and is an inventor on over 40 issued patents. Mr. Isaacs holds a B.A. degree in Biochemistry from University of California, Berkeley, and had graduate training in organic chemistry in the Ph.D. program in the Department of Chemistry at Berkeley.